Potassium: Benefits, Best Forms, Dosing, and Side Effects

Potassium is an essential mineral and the most abundant intracellular cation in the human body. It is required for normal cell function because of its role in maintaining intracellular fluid volume and transmembrane electrochemical gradients [1][2]. This comprehensive guide covers the evidence on potassium's health benefits, the different supplemental forms, recommended dosing, safety considerations, drug interactions, and the best dietary sources.

Normal serum concentrations of potassium range from approximately 3.6 to 5.0 mmol/L [1][3]. Potassium is absorbed via passive diffusion primarily in the small intestine, with approximately 90% of ingested potassium being absorbed [1][5]. The kidneys are the primary regulators of potassium balance, and potassium deficiency is a growing public health concern — an analysis of over 50,000 Americans from 1999 to 2016 found that blood potassium levels are declining and the prevalence of deficiency has increased by 7.3% [6].

Table of Contents

• Overview
• Forms and Bioavailability
• Evidence for Benefits
• Recommended Dosing
• Safety and Side Effects
• Drug Interactions
• Dietary Sources
• References

Overview

Potassium is an essential mineral involved in proper functioning of the nervous system, skeletal system, cardiac muscle, and metabolism, as well as maintaining normal blood pressure [1][2][3]. The total amount of potassium in the adult body is approximately 45 millimole (mmol) per kilogram of body weight — roughly 140 g for a 175-pound adult [1]. Most potassium resides inside cells, with only a small amount in extracellular fluid. The intracellular concentration of potassium is about 30 times higher than the extracellular concentration, and this gradient is maintained via the sodium-potassium (Na+/K+) ATPase transporter [1][2].

This transmembrane electrochemical gradient is essential for proper nerve transmission, muscle contraction, kidney function, and cardiac rhythm [1][2][3]. Potassium also has a strong relationship with sodium — the main regulator of extracellular fluid volume — and plays a critical role in blood pressure regulation by promoting vasodilation and increasing urinary sodium excretion [1][4].

Deficiency Is Increasing

An analysis of over 50,000 men, women, and children (ages 12 to 80) from NHANES from 1999 to 2016 found that average annual blood levels of potassium decreased from 4.14 mmol/L to 3.97 mmol/L, and the prevalence of potassium deficiency increased by 7.3%. Deficiency was more common in non-Hispanic black than non-Hispanic white individuals [6]. A decline of potassium in crop soil and fertilizer, increased consumption of processed foods, and decreased consumption of fruits and vegetables may contribute to these trends [6].

According to NHANES 2013-2014 data, the average daily potassium intake from foods is 3,016 mg for men and 2,320 mg for women aged 20 and over — well below the Adequate Intake levels of 3,400 mg and 2,600 mg, respectively [1][7]. Potassium is identified as a "nutrient of public health concern" by the Dietary Guidelines for Americans [7].

Symptoms of Deficiency

Severe potassium deficiency causes hypokalemia (serum potassium level below 3.6 mmol/L), which affects up to 21% of hospitalized patients, most often due to diuretic use [1][8]. Symptoms progress with severity:

• Mild: Constipation, fatigue, muscle weakness, malaise, listlessness, mood changes
• Moderate: Numbness, tingling, muscle cramps, nausea, vomiting, irrational behavior
• Severe (serum potassium below ~2.5 mmol/L): Polyuria, muscular paralysis, poor respiration, cardiac arrhythmias, encephalopathy. Severe hypokalemia can be life threatening due to its effects on cardiac function [1][3].

Causes of Deficiency

Hypokalemia is rarely caused by low dietary potassium intake alone. Common causes include diuretic medications (both loop and thiazide diuretics increase urinary potassium excretion), gastrointestinal losses from prolonged vomiting, diarrhea, or laxative abuse, inflammatory bowel disease, beta2-receptor agonists, proton-pump inhibitors, corticosteroids, xanthines (theophylline, caffeine), and overdosage of insulin or verapamil [1][3][9].

GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) have also been linked with hypokalemia. In two case reports, two women in their 40s developed low blood potassium requiring hospitalization 1.5 to 6 months after starting semaglutide [10].

Magnesium and Potassium: A Critical Connection

Approximately 50% of individuals with chronically low potassium levels also have magnesium deficiency [11][12]. If magnesium deficiency is not addressed, it may be harder to correct potassium deficiency. Magnesium activates the "pump" that regulates potassium levels within cells — when magnesium levels are low, pump activity decreases, resulting in loss of potassium from skeletal muscle cells and increased urinary excretion [12][13]. In people with concurrent hypomagnesemia and hypokalemia, both should be treated simultaneously [1][11].

Forms and Bioavailability

Potassium is available in supplements in many forms. More than 90% of potassium is absorbed in the gastrointestinal tract regardless of form, and nearly all common forms are absorbed equally well [3][5][14]. A 2016 dose-response trial found that humans absorb about 94% of potassium gluconate from supplements, similar to the absorption rate from potatoes [15].

Form	Elemental K (%)	Key Properties	Common Uses
Potassium Chloride (KCl)	52%	Highest elemental K per gram. Bitter/metallic taste. May irritate GI tract at higher doses [3][14].	Salt substitutes, prescription treatment, BP trials
Potassium Citrate	38.3%	Well-absorbed. Citrate raises urine pH and forms complexes with calcium [17][18].	Kidney stone prevention, general supplementation
Potassium Gluconate	16.7%	Less bitter taste. Good tolerability. Low elemental content [3][14].	General supplementation
Potassium Bicarbonate	~39%	Alkalizing effect. May support bone health. Case reports for kidney stones [19][20].	Bone health, kidney stone management
Potassium Phosphate	~28%	Phosphate may reduce urinary calcium in hypercalciuria [21].	Kidney stone disease
Potassium Aspartate	~25%	Sometimes combined with magnesium aspartate. Limited data.	Combined mineral supplements
Potassium Acetate	~40%	Well-absorbed. Less commonly available OTC.	Specialty formulations

Key Principles for Form Selection

For general supplementation: Potassium gluconate and potassium citrate are well-tolerated choices. Potassium gluconate has a less bitter taste, while potassium citrate provides additional citrate for kidney health [3][14].

For kidney stone prevention: Potassium citrate is preferred because the citrate component — not the potassium itself — interferes with calcium stone formation [17][18].

For blood pressure: Most clinical trials used potassium chloride. Potassium-enriched salt substitutes (25-75% potassium chloride) offer a practical way to increase potassium and reduce sodium [22][23].

For bone health: Potassium citrate and potassium bicarbonate are preferred over potassium chloride because the alkaline salts help counter metabolic acidosis that may contribute to bone loss [24][25].

Important Label Reading Note

Product names can be misleading. A product labeled "Potassium Gluconate 595 mg" actually contains only about 99 mg of elemental potassium, because potassium makes up just 16.7% of potassium gluconate. Potassium dosage is sometimes expressed in milliequivalents (mEq), where 1 mEq equals 39.09 mg [3].

The 99 mg Supplement Limit

Most potassium supplements are limited to 99 mg per pill because the FDA ruled that oral drug products containing potassium chloride above 99 mg are associated with small-bowel lesions [26][27]. This limit does not apply to liquid, powder, or effervescent tablet forms, which disperse potassium more widely [3].

Dr Brad Stanfield's MicroVitamin includes 99 mg of potassium — the standard supplemental dose designed to help fill dietary gaps without exceeding the safety threshold for capsule forms.

Evidence for Benefits

Blood Pressure

Getting adequate potassium from diet and supplementation may help reduce hypertension, particularly in African-Americans and people who consume excessive sodium [22][28][29].

Meta-analyses: A 2017 meta-analysis of 25 RCTs in 1,163 participants with hypertension found reductions in systolic blood pressure (SBP) by 4.48 mmHg and diastolic blood pressure (DBP) by 2.96 mmHg with potassium supplementation at 1,173-4,692 mg/day for 4-15 weeks [30]. Another meta-analysis of 15 RCTs found the greatest effect in hypertensive patients: SBP reduced by 6.8 mmHg and DBP by 4.6 mmHg [31]. Two earlier meta-analyses of 19 trials [32] and 33 trials [33] had similar findings. The NASEM committee's analysis of 16 trials found potassium supplements lowered SBP by 6.87 mmHg and DBP by 3.57 mmHg, but effects were only significant in hypertensive participants [34].

Ceiling effects: The ACC and AHA recommend 3,500-5,000 mg/day of potassium from foods for people with high blood pressure. The maximum benefit from supplements appears to peak at approximately 1,173 mg/day, and higher supplement doses (>3,128 mg/day) have been linked with increased blood pressure, particularly in those on antihypertensive medication [35][36].

Cochrane Review: A Cochrane Review of 5 trials among 425 adults with primary hypertension found that potassium supplementation at 1,877-4,692 mg/day for 2-4 months did NOT significantly reduce blood pressure [37]. High-dose supplementation (3,900-4,680 mg/day in addition to diet) may actually increase blood pressure [38].

Sodium reduction matters: The AHRQ review found that reducing sodium decreased blood pressure, but adding potassium on top of sodium reduction did not reduce blood pressure further, suggesting some benefit attributed to potassium may be from sodium reduction [34].

Expert consensus: Experts recommend increasing potassium from foods to 3,500-5,000 mg/day and substituting table salt with potassium-enriched salts (~75% NaCl, ~25% KCl), rather than relying on high-dose supplements [35][39][40].

Stroke and Cardiovascular Disease

Higher potassium intakes have been associated with decreased stroke risk. A meta-analysis of 11 prospective cohort studies (247,510 adults) found a 1,640 mg/day higher potassium intake was associated with a 21% lower stroke risk [42]. A meta-analysis of 9 cohort studies found a 24% lower stroke risk [43].

A 2016 meta-analysis of 16 cohort studies (639,440 participants) found the highest potassium intakes (median 4,027 mg/day) conferred a 15% lower stroke risk versus the lowest intakes. Approximately 3,500 mg/day was associated with the lowest stroke risk. Even when blood pressure was accounted for, higher potassium intakes still produced a significant 13% lower stroke risk — suggesting mechanisms beyond blood pressure, such as improved endothelial function and reduced free radical formation [44].

The FDA has approved the health claim: "Diets containing foods that are a good source of potassium and that are low in sodium may reduce the risk of high blood pressure and stroke" [45].

Salt Substitutes and Cardiovascular Outcomes

A meta-analysis found that potassium-enriched salt substitutes (containing 25-67% potassium) reduced SBP by 4.9 mmHg and DBP by 1.5 mmHg [46].

SSaSS trial: A landmark 5-year study in China among nearly 21,000 adults with a history of stroke or high blood pressure found that a salt substitute (25% KCl, 75% NaCl) reduced stroke risk by 14%, major cardiovascular events by 13%, and death by 12% compared to regular salt — without increasing hyperkalemia risk [23]. Further analysis found the salt substitute reduced stroke-related death by 21% among those with prior stroke, mainly via reductions in hemorrhagic stroke (-30%) [47].

Elderly care facility study: Among 1,219 elderly residents in China (average BP 137.5/80.5 mmHg), a salt substitute (62.5% NaCl, 25% KCl, 12.5% flavoring) over 2 years reduced cardiovascular events by 34% and heart disease death by 36%. Hyperkalemia risk was increased (7.0% vs 2.4%) but no significant kidney dysfunction occurred [48].

Limitation: None of these studies were conducted in the U.S., where most sodium comes from processed foods rather than home-use table salt [3].

Kidney Stone Prevention

Certain forms of potassium may reduce kidney stone risk. The mechanism primarily involves citrate — which forms complexes with urinary calcium and increases urine pH, inhibiting calcium oxalate crystal formation [17][49].

Patients taking 6,480 mg (60 mEq) of potassium citrate daily had no stone recurrence after one year, compared to 28.5% recurrence without treatment [50]. A 3-year RCT of 57 patients with recurrent stones found potassium citrate (1,173-2,346 mg potassium) significantly reduced stone formation versus placebo [51]. A 2015 Cochrane Review of 7 studies (477 participants) confirmed that potassium citrate salts significantly reduced new stones and decreased stone size [17].

A potassium complex providing 1,638 mg potassium, 252 mg magnesium, and 3,971 mg citrate daily for up to 3 years reduced kidney stone recurrence by 85% versus placebo [52]. Potassium phosphate at 2,496 mg (as potassium phosphate) reduced urinary calcium by 30-35% over 4 years in patients with absorptive hypercalciuria [21].

Observational data: Men with the highest potassium intakes (≥4,042 mg/day) had a 51% lower risk of kidney stones over 4 years [53]. Women consuming >4,099 mg/day had a 35% lower risk over 12 years in the Nurses' Health Study [54].

Note: Most potassium citrate supplements provide only 99 mg of potassium, far below clinical trial doses. Higher doses require medical supervision [3].

Bone Health

Potassium may support bone health through its effect on acid-base balance. Alkaline potassium salts (citrate, bicarbonate — but not chloride) may help counter metabolic acidosis that contributes to bone loss [55][56].

In the Framingham Heart Study, higher potassium intake was associated with greater bone mineral density in 628 elderly participants [57]. The DASH diet significantly reduced bone turnover markers [58].

Clinical trials: Potassium citrate at 2,346-3,519 mg potassium for 6 months reduced urinary calcium excretion in 52 adults over 55 [59]. In 201 adults aged 65+, potassium citrate (2,346 mg) plus calcium and vitamin D3 for 2 years significantly increased lumbar spine bone mineral density [60]. Potassium bicarbonate (2,893-4,340 mg/day) for 84 days reduced bone turnover markers [61]. However, potassium citrate at 723-2,170 mg for 2 years did NOT improve bone density in 276 postmenopausal women [62].

Blood Glucose Control and Type 2 Diabetes

Potassium is needed for insulin secretion, and hypokalemia can impair insulin secretion and lead to glucose intolerance [1][2][63].

Observational: In 1,066 adults aged 18-30, those with the lowest urinary potassium levels were more than twice as likely to develop type 2 diabetes over 15 years [64]. Among 84,360 women in the Nurses' Health Study, the highest potassium intake was associated with a 38% lower diabetes risk over 6 years [65]. Associations appear stronger in African Americans [64][66].

Clinical trial: In 29 African American adults with prediabetes, 1,564 mg potassium for 3 months significantly lowered fasting glucose but did not improve glucose tolerance test results [68]. More RCTs are needed.

Rheumatoid Arthritis

Among 155 people with RA, increasing total daily potassium to ~5,600 mg modestly decreased self-reported pain by 2.23 points (0-10 scale), but did not improve swollen joints, inflammation markers, or analgesic use [70].

Muscle Cramps and Restless Legs

Despite common assumptions, nighttime and exercise-related muscle cramps do not appear to be related to potassium levels [71]. There are no published, double-blind clinical studies on potassium for muscle cramps. A small uncontrolled study found some benefit for restless legs syndrome at 391 mg potassium daily, but the lack of a control group makes this inconclusive [72].

COVID-19 and Hypokalemia

Among 175 COVID-19 patients in China, 39% had hypokalemia and 22% had severe hypokalemia. Supplementing ~3 g potassium daily corrected deficiencies in most patients [73]. A study of 290 Italian patients confirmed hypokalemia was common but mild and not associated with mortality [74]. The mechanism involves SARS-CoV-2 inactivating ACE2, leading to excess renal potassium excretion [73].

Recommended Dosing

Adequate Intakes (AIs)

The 2019 NASEM Adequate Intakes replaced older (2005) recommendations that set the adult AI at 4,700 mg [34][75]:

Age Group	Male (mg/day)	Female (mg/day)
1-3 years	2,000	2,000
4-8 years	2,300	2,300
9-13 years	2,500	2,300
14-18 years	3,000	2,300
19-50+ years	3,400	2,600
Pregnancy	--	2,900
Lactation	--	2,800

No Upper Limit Established

Tolerable Upper Intake Levels have not been established for potassium because the kidneys excrete excess amounts in healthy individuals [1][34]. However, people with compromised kidney function should exercise caution. Those requiring dialysis are generally advised to restrict potassium to ~2,000 mg daily [3].

Supplementation Dosing by Indication

• Preventing potassium loss: 200-400 mg taken 3-4 times daily (total 600-1,600 mg/day) [3]
• Treating deficiency: Approximately double the preventive dose, under physician guidance [3]
• Blood pressure (from food): 3,500-5,000 mg/day total. Supplement doses above ~3,128 mg/day may paradoxically increase BP [35][39]
• Kidney stone prevention: 1,173-6,480 mg/day as potassium citrate (requires medical supervision) [17][50][51]
• Bone health: 2,346-4,340 mg/day as potassium citrate or bicarbonate in trials [59][60][61]

Practical Considerations

Because most supplements contain only 99 mg per pill, reaching therapeutic doses requires many pills. Powder, liquid, or effervescent forms are more practical and likely safer for higher doses because they avoid localized intestinal irritation [3]. The most practical approach for most people is to increase dietary potassium (fruits, vegetables, legumes, potatoes) and use potassium-enriched salt substitutes, with a modest supplement to help fill gaps.

Safety and Side Effects

Common Side Effects

Potassium supplements may cause diarrhea, nausea, stomach pain, mild gas, and vomiting — these may be reduced by taking with meals. Less common but more serious effects include confusion, irregular heartbeat, numbness or tingling in hands/feet/lips, shortness of breath, and anxiety [3][9].

Esophageal and Intestinal Risks

Potassium chloride can injure the esophagus if a pill gets stuck during swallowing [76]. High doses (>99 mg) in enteric-coated pills have been linked to small-bowel lesions causing obstruction, hemorrhage, and perforation [26][27]. The FDA requires oral drugs with 100+ mg of potassium per coated tablet to carry a warning. This does not apply to liquid, effervescent, or powder forms [3].

Hyperkalemia

In healthy people with normal kidney function, high dietary potassium does not pose a risk [1][34]. However, hyperkalemia can occur in people with impaired kidney function or those taking certain medications. Very high supplement doses could theoretically exceed kidney excretion capacity even in healthy people, though chronic doses up to 15,600 mg for 5 days in healthy subjects raised plasma potassium but not beyond normal range [1].

Symptoms of hyperkalemia: mild cases are often asymptomatic; moderate cases involve muscle weakness and paresthesias; severe cases can cause paralysis, heart palpitations, and life-threatening cardiac arrhythmias [1].

Kidney Disease

People with kidney disease should use potassium only under medical supervision [3]. However, too little potassium is also a concern: among 415 dialysis patients, those consuming only ~543 mg/day had a two-fold greater mortality risk compared to those consuming ~2,600 mg [77].

Other Risks

Premenstrual syndrome: Higher potassium intake (median 3,717 mg/day) was associated with 46% higher PMS risk compared to lower intake (median 2,319 mg/day) in a large U.S. study [78].

Salt substitute concerns: People with kidney disease should not use potassium salt substitutes without medical supervision. An 88-year-old man with chronic kidney disease developed hyperkalemia (7.5 mEq/L) after using a salt substitute for one month [79]. Salt substitutes may also increase risk for those with diabetes, coronary artery disease, or heart failure [3].

Drug Interactions

Drugs That Increase Potassium (Risk of Hyperkalemia)

Drug Class	Examples	Clinical Concern
ACE inhibitors	Benazepril, captopril, enalapril, lisinopril	~20% experience mild K+ elevations. Severe elevations in ~0.8%. Life-threatening cases documented [9][81][82].
ARBs	Losartan, irbesartan, olmesartan, valsartan	~31% experience mild elevations; severe in ~2.8%. Case of K+ 9.2 mmol/L on losartan [9][83].
K+-sparing diuretics	Amiloride, spironolactone, triamterene	Reduce renal K+ excretion. Monitor closely, especially with impaired kidneys [1][84].
Trimethoprim/sulfamethoxazole	Bactrim, Septra	Impairs K+ excretion. Avoid K+ supplements without supervision [9].

Drugs That Decrease Potassium (Risk of Hypokalemia)

Drug Class	Examples	Clinical Concern
Loop diuretics	Furosemide, bumetanide	Increase urinary K+ excretion. Supplementation may be needed [1][84].
Thiazide diuretics	Chlorothiazide, hydrochlorothiazide, metolazone	Increase urinary K+ excretion. Monitor levels [1][84].
Beta2-receptor agonists	Albuterol, ephedrine	Transcellular shift lowers serum K+ [9].
Corticosteroids	Hydrocortisone, cortisone, methylprednisolone	Average to large doses may deplete K+ [9].
PPIs	Omeprazole, esomeprazole, pantoprazole	Can cause hypokalemia with chronic use [9].
Laxatives	Various	Repeated use increases fecal K+ loss [1].
GLP-1 agonists	Semaglutide (Ozempic, Wegovy)	Uncommon but documented cases of hypokalemia [10].

Dietary Sources

Foods are the best source of potassium for most people. The body absorbs approximately 85-90% of dietary potassium [1]. The forms of potassium in foods (phosphate, sulfate, citrate) differ from supplements (typically chloride) [4].

Top Food Sources

Food	Serving	Potassium (mg)
Kidney beans, canned	1 cup	2,587
White potato, baked with skin	1 large	1,627
Red sockeye salmon	1 filet (~100 g)	1,037
Banana, mashed	1 cup	806
Apricots, dried	1/2 cup	755
Lentils, cooked	1 cup	731
Acorn squash, mashed	1 cup	644
Prunes, dried	1/2 cup	635
Raisins	1/2 cup	618
Potato, baked (flesh only)	1 medium	610
Orange juice	1 cup	496
Soybeans, boiled	1/2 cup	443
Banana	1 medium	422
Milk, 1%	1 cup	366
Spinach, raw	2 cups	334
Chicken breast, grilled	3 oz	332
Salmon, Atlantic, farmed	3 oz	326
Beef, top sirloin, grilled	3 oz	315
Tomato, raw	1 medium	292

Source: USDA FoodData Central [89]; NIH ODS [1][14]; ConsumerLab [3].

Practical Notes

• Refining grains reduces potassium: Whole-wheat flour and brown rice are much higher in potassium than their refined counterparts [1].
• Top sources in the U.S.: Milk, coffee, tea, other nonalcoholic beverages, and potatoes for adults. Milk, fruit juice, potatoes, and fruit for children [90][91].
• Salt substitutes: Potassium-enriched salt substitutes (25-50% KCl) provide a practical way to reduce sodium and increase potassium simultaneously [40][46].

References

1. National Academies of Sciences, Engineering, and Medicine. "Dietary Reference Intakes for Sodium and Potassium." Washington, DC: The National Academies Press; 2019. https://doi.org/10.17226/25353

2. Stone MS, Martyn L, Weaver CM. "Potassium intake, bioavailability, hypertension, and glucose control." Nutrients. 2016;8(7):444. https://doi.org/10.3390/nu8070444

3. ConsumerLab. "Potassium Supplements Review." Accessed 2025. https://www.consumerlab.com/reviews/potassium-supplements-review/potassium/

4. He FJ, MacGregor GA. "Beneficial effects of potassium on human health." Physiol Plant. 2008;133(4):725-35. https://pubmed.ncbi.nlm.nih.gov/18724413/

5. Bailey JL, Sands JM, Franch HA. "Water, electrolytes, and acid-based metabolism." In: Modern Nutrition in Health and Disease. 11th ed. 2014:102-32.

6. Sun H. "Potassium intake and potassium deficiency in the US population, NHANES 1999-2016." J Am Coll Nutr. 2020. https://pubmed.ncbi.nlm.nih.gov/31855136/

7. U.S. Department of Health and Human Services. "2015-2020 Dietary Guidelines for Americans." 2015.

8. Paice BJ et al. "Record linkage study of hypokalaemia in hospitalized patients." Postgrad Med J. 1986;62(725):187-91. https://pubmed.ncbi.nlm.nih.gov/3714611/

9. Makunts T et al. "Potassium-lowering effects of medications." Sci Rep. 2019. See also: Medrol Prescribing Information, 2024; Veltri KT. P T. 2015.

10. Grennan Q et al. "Hypokalemia associated with semaglutide." Cureus. 2025.

11. Huang CL, Kuo E. "Mechanism of hypokalemia in magnesium deficiency." J Am Soc Nephrol. 2007;18(10):2649-52. https://doi.org/10.1681/ASN.2007070792

12. Whang R et al. "Magnesium and potassium interrelationships." Arch Intern Med. 1992;152(1):40-5. https://pubmed.ncbi.nlm.nih.gov/1728927/

13. Rude RK. "Magnesium." In: Encyclopedia of Dietary Supplements. 2nd ed. 2010:527-37.

14. NIH Office of Dietary Supplements. "Potassium — Health Professional Fact Sheet." Updated June 2, 2022. https://ods.od.nih.gov/factsheets/Potassium-HealthProfessional/

15. Macdonald-Clarke CJ et al. "Bioavailability of potassium from potatoes and potassium gluconate." Am J Clin Nutr. 2016;104(2):346-53. https://pubmed.ncbi.nlm.nih.gov/27413130/

16. Levene DL. "The absorption of potassium chloride — liquid vs. tablet." Can Med Assoc J. 1973;108(12):1480. https://pubmed.ncbi.nlm.nih.gov/4712696/

17. Phillips R et al. "Citrate salts for preventing and treating calcium containing kidney stones." Cochrane Database Syst Rev. 2015;(10):CD010057. https://doi.org/10.1002/14651858.CD010057.pub2

18. Soygur T et al. "Potassium citrate in preventing kidney stone recurrence." J Endourol. 2002;16(9):687-90. https://pubmed.ncbi.nlm.nih.gov/12490024/

19. Barbera M et al. "Potassium bicarbonate and kidney stone dissolution." Arch Ital Urol Androl. 2016;88(3):236-8. https://pubmed.ncbi.nlm.nih.gov/27711109/

20. Pak CYC et al. "Potassium bicarbonate and kidney stones." Kidney Int. 1986;30(3):422-8.

21. Heller HJ et al. "Potassium phosphate reduces urinary calcium in hypercalciuria." J Urol. 1998;159(5):1451-6. https://pubmed.ncbi.nlm.nih.gov/9554332/

22. Chan Q et al. "Potassium and blood pressure." Hypertension. 2023. https://doi.org/10.1161/HYPERTENSIONAHA.122.20017

23. Neal B et al. "Effect of salt substitution on cardiovascular events and death." N Engl J Med. 2021;385(12):1067-77. https://doi.org/10.1056/NEJMoa2105675

24. Tucker KL et al. "Potassium and bone mineral density." Am J Clin Nutr. 1999;69(4):727-36. https://pubmed.ncbi.nlm.nih.gov/10197575/

25. Dawson-Hughes B et al. "Potassium bicarbonate supplementation lowers bone turnover." J Bone Miner Res. 2015;30(11):2103-11. https://pubmed.ncbi.nlm.nih.gov/25989378/

26. U.S. FDA. Code of Federal Regulations Title 21. 21CFR201.306. Potassium salt preparations. 2017.

27. Allen AC et al. "Potassium-induced small bowel lesions." JAMA. 1965;193:1001-6. https://pubmed.ncbi.nlm.nih.gov/14325113/

28. Suh A et al. "Potassium and blood pressure in African Americans." Kidney Int. 2004.

29. Matlou SM et al. "Potassium and blood pressure." J Hypertens. 1986;4(suppl 6):S61-S63.

30. Filippini T et al. "Potassium supplementation on blood pressure in hypertensive subjects: meta-analysis." Int J Cardiol. 2017;230:127-35. https://pubmed.ncbi.nlm.nih.gov/28024910/

31. Binia A et al. "Daily potassium intake and blood pressure: meta-analysis." J Hypertens. 2015;33(8):1509-20. https://pubmed.ncbi.nlm.nih.gov/26039623/

32. Cappuccio FP, MacGregor GA. "Potassium supplementation and blood pressure: meta-analysis." J Hypertens. 1991;9(5):465-73. https://pubmed.ncbi.nlm.nih.gov/1649867/

33. Whelton PK et al. "Effects of oral potassium on blood pressure: meta-analysis." JAMA. 1997;277(20):1624-32. https://pubmed.ncbi.nlm.nih.gov/9168293/

34. AHRQ. "Sodium and Potassium Intake: Effects on Chronic Disease Outcomes." 2018. See also: NASEM, DRIs for Sodium and Potassium, 2019.

35. Jones DW et al. "Potassium and blood pressure guidelines." Hypertension. 2025. See also: McEvoy JW et al. Eur Heart J. 2024.

36. Azizi M et al. "Salt substitution and blood pressure." JAMA. 2026.

37. Dickinson HO et al. "Potassium supplementation for primary hypertension." Cochrane Database Syst Rev. 2006;(3):CD004641. https://pubmed.ncbi.nlm.nih.gov/16856051/

38. Filippini T et al. "High-dose potassium supplementation and blood pressure." J Am Heart Assoc. 2020. https://doi.org/10.1161/JAHA.119.015719

39. Whelton PK et al. "2017 ACC/AHA Guideline for High Blood Pressure." Hypertension. 2018;71(6):e13-e115. https://doi.org/10.1161/HYP.0000000000000065

40. Xu J et al. "Potassium-enriched salt substitutes for hypertension." Hypertension. 2024.

41. Aaron KJ, Sanders PW. "Dietary salt and potassium in cardiovascular health." Mayo Clin Proc. 2013;88(9):987-95. https://pubmed.ncbi.nlm.nih.gov/24001491/

42. D'Elia L et al. "Potassium intake, stroke, and cardiovascular disease: meta-analysis." J Am Coll Cardiol. 2011;57(10):1210-9. https://pubmed.ncbi.nlm.nih.gov/21371638/

43. Aburto NJ et al. "Increased potassium intake and cardiovascular risk: meta-analyses." BMJ. 2013;346:f1378. https://doi.org/10.1136/bmj.f1378

44. Vinceti M et al. "Potassium Intake and the Risk of Stroke: meta-analysis." J Am Heart Assoc. 2016;5(10):e004210. https://doi.org/10.1161/JAHA.116.004210

45. U.S. FDA. "Food Labeling: Revision of the Nutrition and Supplement Facts Labels." Federal Register. 2016;81(103):33894-33895.

46. Raquel G et al. "Salt substitutes and blood pressure: meta-analysis." Hypertension. 2020.

47. Ding J et al. "Salt substitute and stroke outcomes." JAMA Cardiol. 2025. https://doi.org/10.1001/jamacardio.2024.5264

48. Yuan Y et al. "Salt substitute and cardiovascular events in elderly care." Nat Med. 2023. https://doi.org/10.1038/s41591-023-02435-x

49. Maalouf NM et al. "Hypercalciuria and dietary protein." J Clin Endocrinol Metab. 2011;96(12):3733-40. https://pubmed.ncbi.nlm.nih.gov/21937618/

50. Soygur T et al. "Potassium citrate prevents kidney stone recurrence." J Endourol. 2002;16(9):687-90. https://pubmed.ncbi.nlm.nih.gov/12490024/

51. Barcelo P et al. "Potassium citrate in calcium nephrolithiasis." J Urol. 1993;150(6):1761-4. https://pubmed.ncbi.nlm.nih.gov/8230497/

52. Ettinger B et al. "Potassium complex and kidney stone recurrence." J Urol. 1997;158(6):2069-73. https://pubmed.ncbi.nlm.nih.gov/9366314/

53. Curhan GC et al. "Dietary calcium and kidney stone risk." N Engl J Med. 1993;328(12):833-8. https://pubmed.ncbi.nlm.nih.gov/8441427/

54. Curhan GC et al. "Dietary calcium and kidney stone risk in women." Ann Intern Med. 1997;126(7):497-504. https://pubmed.ncbi.nlm.nih.gov/9092314/

55. Weaver CM. "Potassium and health." Adv Nutr. 2013;4(3):368S-77S. https://pubmed.ncbi.nlm.nih.gov/23674806/

56. Hanley DA, Whiting SJ. "Dietary acid and bone loss." J Clin Densitom. 2013;16(4):420-5. https://pubmed.ncbi.nlm.nih.gov/24063846/

57. Tucker KL et al. "Potassium and bone mineral density." Am J Clin Nutr. 1999;69(4):727-36. https://pubmed.ncbi.nlm.nih.gov/10197575/

58. Lin PH et al. "DASH diet and bone turnover." J Nutr. 2003;133(10):3130-6. https://pubmed.ncbi.nlm.nih.gov/14519796/

59. Moseley KF et al. "Potassium citrate and calcium balance." J Bone Miner Res. 2013;28(3):497-504. https://pubmed.ncbi.nlm.nih.gov/23060044/

60. Jehle S et al. "Potassium citrate on bone density in older adults." J Clin Endocrinol Metab. 2013;98(1):207-17. https://pubmed.ncbi.nlm.nih.gov/23162100/

61. Dawson-Hughes B et al. "Potassium bicarbonate and bone turnover." J Bone Miner Res. 2015;30(11):2103-11. https://pubmed.ncbi.nlm.nih.gov/25989378/

62. Macdonald HM et al. "Potassium citrate and bone in postmenopausal women." Am J Clin Nutr. 2008;88(2):465-74. https://pubmed.ncbi.nlm.nih.gov/18689384/

63. Zillich AJ et al. "Thiazide diuretics, potassium, and diabetes." Hypertension. 2006;48(2):219-24. https://pubmed.ncbi.nlm.nih.gov/16801488/

64. Chatterjee R et al. "Potassium and type 2 diabetes: the CARDIA Study." Diabetologia. 2012;55(5):1295-303. https://pubmed.ncbi.nlm.nih.gov/22322920/

65. Colditz GA et al. "Diet and diabetes risk in women." Am J Clin Nutr. 1992;55(5):1018-23. https://pubmed.ncbi.nlm.nih.gov/1315120/

66. Chatterjee R et al. "Potassium and diabetes: the ARIC study." Arch Intern Med. 2010;170(19):1745-51. https://pubmed.ncbi.nlm.nih.gov/20975023/

67. Chatterjee R et al. "Potassium and diabetes risk: the MESA study." PLoS One. 2016;11(7):e0157252. https://pubmed.ncbi.nlm.nih.gov/27391103/

68. Chatterjee R et al. "Potassium supplements and glucose in prediabetes." Am J Clin Nutr. 2017;106(6):1431-8. https://pubmed.ncbi.nlm.nih.gov/29070559/

69. Nuki G et al. "Potassium and rheumatoid arthritis." Ann Rheum Dis. 1975;34(suppl):52-3.

70. Toktam F et al. "Potassium supplementation in rheumatoid arthritis." medRxiv. 2022. (Preprint.)

71. Allen RE, Kirby KA. "Nocturnal leg cramps." Am Fam Physician. 2012;86(4):350-5. https://pubmed.ncbi.nlm.nih.gov/22963024/

72. Rauf M et al. "Potassium citrate in restless legs syndrome." Pharm Pharmacol Int J. 2016.

73. Chen D et al. "Hypokalemia and COVID-19." medRxiv. 2020. (Preprint.)

74. Alfano G et al. "Hypokalemia in COVID-19 patients in Italy." medRxiv. 2020. (Preprint.)

75. National Academies of Sciences. "DRIs for Sodium and Potassium." 2019. (Previous AI for adults was 4,700 mg in 2005.)

76. Hey H et al. "Potassium chloride and esophageal injury." Br Med J. 1982;285(6343):717-8.

77. Narasaki Y et al. "Potassium intake and mortality in dialysis." J Renal Nutr. 2020. https://pubmed.ncbi.nlm.nih.gov/31753764/

78. Chocano-Bedoya PO et al. "Potassium and PMS risk." Am J Epidemiol. 2013;177(10):1118-27. https://doi.org/10.1093/aje/kws363

79. Kusunoki T et al. "Salt substitute-induced hyperkalemia." Cureus. 2025.

80. Abe T et al. "Mango-induced hyperkalemia." Case Rep Neurol Med. 2012. https://doi.org/10.1155/2012/926152

81. Raebel MA. "Hyperkalemia with ACE inhibitors and ARBs." Cardiovasc Ther. 2012;30(3):e156-66. https://pubmed.ncbi.nlm.nih.gov/21883995/

82. Epstein M. "Hyperkalemia and RAAS blockade." J Clin Hypertens. 2009;11(1):55-60. https://pubmed.ncbi.nlm.nih.gov/19125861/

83. Dockery MA et al. "Life-threatening hyperkalemia from losartan." Mil Med. 2022.

84. Sarafidis PA et al. "Diuretics and electrolyte disorders." Expert Opin Drug Saf. 2010;9(2):259-73. https://pubmed.ncbi.nlm.nih.gov/20095753/

85. Fang L et al. "ACE inhibitors and COVID-19." Lancet Respir Med. 2020;8(4):e21. https://doi.org/10.1016/S2213-2600(20)30116-8

86. Diaz JH. "ACE inhibitors, ARBs, and COVID-19." J Travel Med. 2020;27(3):taaa041. https://doi.org/10.1093/jtm/taaa041

87. Danser AHJ et al. "RAAS blockers and COVID-19." Hypertension. 2020;75(6):1382-5. https://doi.org/10.1161/HYPERTENSIONAHA.120.15082

88. de Simone G et al. "ESC position on ACE-inhibitors and ARBs." European Society of Cardiology. 2020.

89. USDA, Agricultural Research Service. "FoodData Central." https://fdc.nal.usda.gov/

90. O'Neil CE et al. "Food sources of nutrients among US adults." Nutrients. 2012;4(12):2097-120. https://pubmed.ncbi.nlm.nih.gov/23363999/

91. Keast DR et al. "Food sources of nutrients among US children." Nutrients. 2013;5(1):283-301. https://pubmed.ncbi.nlm.nih.gov/23340318/